In terms of men's health issues, prostate cancer features high on the agenda. It's the second most diagnosed cancer in men globally—closely followed by lung cancer. And it's the most common cancer in men in the UK.
Apr 24, 2024
0
3
Mayo Clinic researchers have used a new approach to chemotherapy to more than double the typical survival rate for patients with stomach cancer and peritoneal metastasis, which is cancer that has spread to the lining of the ...
Apr 23, 2024
0
1
In a study of patients who smoked when they were diagnosed with laryngeal cancer, those who quit smoking before starting chemotherapy or radiation responded better to treatment, were less likely to need their voice boxes ...
Apr 23, 2024
0
0
Only 4% of cancer survivors are fully adherent to current American Cancer Society (ACS) nutrition and physical activity guidelines, according to a study published online April 18 in JAMA Oncology.
Apr 23, 2024
0
1
The U.S. Food and Drug Administration (FDA) has approved the immunotherapy-boosting drug N-803, which is marketed under the brand name Anktiva, to be used in combination with the immunotherapy Bacillus Calmette-Guerin (BCG) ...
Apr 23, 2024
0
1
Lateropulsion, a clinical condition that results in the body leaning to one side, affects about half of all stroke survivors.
Apr 23, 2024
0
26
A team of Adelaide and U.S. researchers has discovered a link between a less common form of rheumatoid arthritis and gene mutations found in blood cancer.
Apr 23, 2024
0
1
MPs have recently voted to ban anyone in England born after 2009 from buying cigarettes, as part of the government's plan to achieve a smoke-free generation.
Apr 23, 2024
0
0
About six out of 10 working-age adults hit with a cancer diagnosis say it put real pressure on their financial survival, a new report finds.
Apr 23, 2024
0
0
Colorectal cancer (CRC) is the second most common cancer in the United States. This highlights the importance of early detection and treatment of precancerous lesions like large polyps. Endoscopy offers a minimally invasive ...
Apr 22, 2024
0
0
